Skip to main content
Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1681 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2026-01-19 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 1681

About Consun Pharmaceutical Group Limited

http://www.chinaconsun.com

Consun Pharmaceutical Group Limited is a modern pharmaceutical enterprise engaged in the integrated research, development, manufacturing, and marketing of pharmaceutical products. The company's core business is segmented into Modern Chinese Medicines (MCM) and Medical Contrast Medium products. The MCM portfolio targets major therapeutic areas, including chronic renal diseases (featuring products like Uremic Clearance Granules), liver and gallbladder conditions, and orthopedic trauma. In the medical imaging field, Consun supplies contrast agents such as Gadopentetate Dimeglumine Injection for magnetic resonance imaging (MRI) and Iopamidol Injection for angiography and neuro-radiology. The enterprise focuses on combining the modernization of Chinese medicine with advanced diagnostic solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details changes in the company's issued shares due to the exercise of share options and the repurchase/cancellation of shares. This type of filing is a standard regulatory requirement for listed companies in Hong Kong to report capital changes, which falls under the 'Share Issue/Capital Change' category.
2026-01-19 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details changes in the company's issued shares due to the exercise of share options and the repurchase/cancellation of shares. According to the provided definitions, announcements regarding new share issues, stock splits, or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2026-01-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific changes in the company's issued shares, including share repurchases and the exercise of share options. According to the filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share issues, share options, and repurchases. Since it is a recurring regulatory filing regarding capital structure and share movements that does not fit into specific categories like 'Share Issue' (which is usually a one-off event) or 'Director's Dealing', it is best classified as a Regulatory Filing (RNS).
2026-01-02 English
Terms of Reference of the Environmental, Social and Governance Committee of the Board of Directors
Environmental & Social Information Classification · 1% confidence The document is a formal 'Terms of Reference' for the Environmental, Social and Governance (ESG) Committee of Consun Pharmaceutical Group Limited. It outlines the committee's constitution, membership, authority, and duties. This type of document falls under corporate governance policies and internal rules, which is best classified as Governance Information (CGR).
2025-12-23 English
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Share Issue/Capital Change Classification · 1% confidence The document is the 'Third Amended and Restated Memorandum and Articles of Association' for Consun Pharmaceutical Group Limited. These documents define the internal governance, rules, and operational structure of a company. In the context of corporate filings, the Memorandum and Articles of Association are fundamental governance documents that are typically filed under the category of Governance Information (CGR) as they outline the board structure, shareholder rights, and internal management rules.
2025-12-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.